SMTL ID : 1ppg.1 (1 other biounit)

The refined 2.3 angstroms crystal structure of human leukocyte elastase in a complex with a valine chloromethyl ketone inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

homo-trimer

Ligands

3 x HMB- ALA- ALA- PRO- VAI- 0QE: MEO-SUCCINYL-ALA-ALA-PRO-VAL CHLOROMETHYLKETONE(Non-covalent)

HMB-ALA-ALA-PRO-VAI-0QE.1: 19 residues within 4Å: Chain A: H.41, L.85, V.168, C.169, F.170, G.171, D.172, S.173, S.188, F.189, V.190, R.191, G.192, G.193 Chain B: Y.199 Chain C: F.170 Ligands: HMB-ALA-ALA-PRO-VAI-0QE.4, HMB-ALA-ALA-PRO-VAI-0QE.7, HMB-ALA-ALA-PRO-VAI-0QE.7 15 PLIP interactions: 13 interactions with chain A, 1 interactions with chain B, 1 interactions with chain C Hydrophobic interactions: A:L.85, A:V.168, A:F.170, A:F.189, A:V.190, C:F.170 Hydrogen bonds: A:G.171, A:D.172, A:S.173, A:S.188, A:V.190, A:V.190, A:G.192, B:Y.199 Water bridges: A:G.193 HMB-ALA-ALA-PRO-VAI-0QE.4: 19 residues within 4Å: Chain A: F.170 Chain B: H.41, L.85, V.168, C.169, F.170, G.171, D.172, S.173, S.188, F.189, V.190, R.191, G.192, G.193 Chain C: Y.199 Ligands: HMB-ALA-ALA-PRO-VAI-0QE.1, HMB-ALA-ALA-PRO-VAI-0QE.1, HMB-ALA-ALA-PRO-VAI-0QE.7 15 PLIP interactions: 13 interactions with chain B, 1 interactions with chain A, 1 interactions with chain C Hydrophobic interactions: B:L.85, B:V.168, B:F.170, B:F.189, B:V.190, A:F.170 Hydrogen bonds: B:G.171, B:D.172, B:S.173, B:S.188, B:V.190, B:V.190, B:G.192, C:Y.199 Water bridges: B:G.193 HMB-ALA-ALA-PRO-VAI-0QE.7: 19 residues within 4Å: Chain A: Y.199 Chain B: F.170 Chain C: H.41, L.85, V.168, C.169, F.170, G.171, D.172, S.173, S.188, F.189, V.190, R.191, G.192, G.193 Ligands: HMB-ALA-ALA-PRO-VAI-0QE.1, HMB-ALA-ALA-PRO-VAI-0QE.4, HMB-ALA-ALA-PRO-VAI-0QE.4 15 PLIP interactions: 13 interactions with chain C, 1 interactions with chain B, 1 interactions with chain A Hydrophobic interactions: C:L.85, C:V.168, C:F.170, C:F.189, C:V.190, B:F.170 Hydrogen bonds: C:G.171, C:D.172, C:S.173, C:S.188, C:V.190, C:V.190, C:G.192, A:Y.199 Water bridges: C:G.193

3 x NAG- NAG- BMA- MAN- NAG- GAL- MAN- FUC: beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-NAG-GAL-MAN-FUC.2: 9 residues within 4Å: Chain A: W.12, Q.121, C.122, L.123, N.144, V.178, C.179, N.180, G.181 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:W.12, A:V.178 Hydrogen bonds: A:Q.121, A:N.180, A:G.181 NAG-NAG-BMA-MAN-NAG-GAL-MAN-FUC.5: 9 residues within 4Å: Chain B: W.12, Q.121, C.122, L.123, N.144, V.178, C.179, N.180, G.181 5 PLIP interactions: 5 interactions with chain B Hydrophobic interactions: B:W.12, B:V.178 Hydrogen bonds: B:Q.121, B:N.180, B:G.181 NAG-NAG-BMA-MAN-NAG-GAL-MAN-FUC.8: 9 residues within 4Å: Chain C: W.12, Q.121, C.122, L.123, N.144, V.178, C.179, N.180, G.181 5 PLIP interactions: 5 interactions with chain C Hydrophobic interactions: C:W.12, C:V.178 Hydrogen bonds: C:Q.121, C:N.180, C:G.181

3 x NAG- NAG- BMA- BMA- NDG- GLC- MAN- FUC: alpha-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-2)-beta-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-BMA-NDG-GLC-MAN-FUC.3: 12 residues within 4Å: Chain A: A.50, V.51, R.52, L.60, R.62, R.63, E.64, P.65, R.67, V.69, A.71, N.95 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:R.52, A:A.71 Hydrogen bonds: A:R.52, A:R.67, A:R.52, A:V.69, A:V.69, A:R.63, A:R.63, A:R.63, A:R.63 Water bridges: A:Q.19, A:R.67 NAG-NAG-BMA-BMA-NDG-GLC-MAN-FUC.6: 12 residues within 4Å: Chain B: A.50, V.51, R.52, L.60, R.62, R.63, E.64, P.65, R.67, V.69, A.71, N.95 2 PLIP interactions: 2 interactions with chain B Hydrophobic interactions: B:R.52, B:A.71 Hydrogen bonds: B:R.52, B:R.67, B:R.52, B:V.69, B:V.69, B:R.63, B:R.63, B:R.63, B:R.63 Water bridges: B:Q.19, B:R.67 NAG-NAG-BMA-BMA-NDG-GLC-MAN-FUC.9: 12 residues within 4Å: Chain C: A.50, V.51, R.52, L.60, R.62, R.63, E.64, P.65, R.67, V.69, A.71, N.95 2 PLIP interactions: 2 interactions with chain C Hydrophobic interactions: C:R.52, C:A.71 Hydrogen bonds: C:R.52, C:R.67, C:R.52, C:V.69, C:V.69, C:R.63, C:R.63, C:R.63, C:R.63 Water bridges: C:Q.19, C:R.67

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wei, A.Z. et al., The refined 2.3 A crystal structure of human leukocyte elastase in a complex with a valine chloromethyl ketone inhibitor. FEBS Lett. (1988)

Release Date

1994-01-31

Peptides

HUMAN LEUKOCYTE ELASTASE: ABC

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
E

B
E

C
E

HUMAN LEUKOCYTE ELASTASE

Related Entries With Identical Sequence